【摘要】 目的分析良性前列腺增生患者经尿道前列腺电切术治疗(TURP)复发后再次行钬激光剜除术(HoLEP)的可行性及术后效果。方法回顾性分析南方医科大学附属东莞人民医院泌尿外科2013年7月～2015年1月收治的15例良性前列腺增生行TURP后再次行HoLEP的患者作为观察组,另外选取同期行HoLEP治疗的50例良性前列腺增生患者作为对照组,比较两组血红蛋白下降水平、手术时间、术后冲洗时间、导尿管留置时间、住院天数,术后并发症以及术后3个月后最大尿流率(Qmax),残余尿(RUV)以及IPSS评分。结果两组手术时间、术后冲洗时间、尿管留置时间、住院时间、血红蛋白下降比比较,差异无统计学意义(P>0.05);两组并发症总发生率比较,差异无统计学意义(P>0.05);两组术后3个月Qmax、RUV及IPSS评分较术前均有改善,差异有统计学意义(P<0.05),但组间比较,差异无统计学意义(P>0.05)。结论对于经尿道前列腺电切术治疗后再次复发的良性前列腺增生患者,再次行HoLEP术安全可行,术后效果良好,可取得与直接行HoLEP相同的效果,值得临床应用。更多还原

【Abstract】 Objective To analyze the feasibility and postoperative effects of holmium laser enucleation(HoLEP) for patients with benign prostatic hyperplasia after recurrence of transurethral resection of the prostate(TURP).Methods A retrospective analysis of 15 patients with benign prostatic hyperplasia who underwent HoLEP after TURP from July 2013 to January 2015 admitted to the Department of Urology, Dongguan People’s Hospital,Southern Medical University, was used as the observation group, and 50 patients who underwent HoLEP treatment during the same period were selected. Patients with benign prostatic hyperplasia served as a control group. The two groups were compared with the decreased levels of hemoglobin,operation time, postoperative washing time, catheter indwelling time, length of stay in hospital, postoperative complications, and maximum urine flow rate(Qmax) 3 months after surgery,residual urine(RUV) and IPSS score.Results There was no statistically significant difference in the operation time,postoperative washing time, catheter indwelling time, hospitalization time, and hemoglobin reduction between the two groups( P>0.05); the difference in the total incidence of complications between the two groups was not statistically significant( P>0.05); The Qmax, RUV and IPSS scores of the two groups were improved 3 months after the operation,the difference was statistically significant( P <0.05), but the comparison of Qmax, RUV and IPSS scores between the two groups was not statistically significant(P>0.05).Conclusion For patients with benign prostatic hyperplasia who relapsed after transurethral resection of the prostate, it is safe and feasible to perform Ho LEP again, and the postoperative effect is good. It can achieve the same effect as direct HoLEP and is worthy of clinical application.更多还原